The FDA-approved smoking cessation pill, varenicline, has emerged as a groundbreaking solution for combating the vaping epidemic among teens and young adults.Recent research from Harvard’s Mass General Brigham highlights that individuals in this age group who utilized varenicline were over three times more successful at quitting vaping than those who relied solely on behavioral counseling.